Paragon Care Limited (PXS) AI Stock Analysis

Paragon Care Limited

(Frankfurt:PXS)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Strong Revenue GrowthSustained double-digit revenue growth shows that Paragon Care is expanding its sales base across healthcare equipment, instruments, and consumables. Continued top-line momentum can support scale benefits and provide a platform for restoring profitability if margin pressure moderates.

Negative Factors

Severe Margin CompressionThe sharp reduction in gross margin and near break-even EBIT show that revenue growth is not currently translating into operating earnings. Persistently thin margins leave little buffer against cost or pricing pressure and make sustainable profitability dependent on meaningful operational improvement.

Paragon Care Limited (PXS) vs. iShares MSCI Germany ETF (EWG)

Market Cap: EUR 160.94M
Dividend Yield: ―
Average Volume (3M): 4,011
Price to Earnings (P/E): -16.1
Beta (1Y): 0.30
Revenue Growth: -0.67%
EPS Growth: -170.67%
Country: Germany
Employees: 869
Sector: Healthcare
Sector Strength: 51
Industry: Medical - Distribution

Paragon Care Limited Business Overview & Revenue Model

Company Description

Paragon Care Limited distributes medical equipment, devices, and consumable products in Australia, New Zealand, and Asia. The company designs, manufactures, and distributes reagent red blood cells, monoclonal blood grouping reagents, and ancillary pr...

Paragon Care Limited Peers Comparison

Overall Rating

UnderperformOutperform

Sector (51)

Financial Indicators

DE:PXS against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
AU:PNV	75Outperform	AUD 625.21M	85.38	8.45%	―	12.94%	-44.50%
AU:SIG	61Neutral	AUD 31.35B	44.32	14.34%	1.47%	―	―
AU:CMP	58Neutral	AUD 47.94M	218.18	0.93%	―	18.54%	―
Sector *	51Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
AU:EPN	47Neutral	AUD 7.78M	66.67	3.34%	―	121.40%	―
AU:TRJ	46Neutral	AUD 38.22M	-62.50	-0.62%	―	-3.05%	86.01%

* Healthcare Sector Average

Performance Comparison

DE:PXS and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
DE:PXS	Paragon Care Limited	0.09	-0.08	-48.24%
AU:SIG	Sigma Healthcare Ltd	2.73	-0.32	-10.61%
AU:PNV	Polynovo Limited	0.91	-0.36	-28.46%
AU:CMP	Compumedics Limited	0.24	-0.10	-28.36%
AU:EPN	Epsilon Healthcare Limited	0.02	-0.00	-16.67%
AU:TRJ	Trajan Group Holdings Ltd	0.25	-0.53	-67.95%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Paragon Care Limited AI Stock Analysis